Nalbuphine as an Intrathecal Adjuvant to 0.5% Hyperbaric Bupivacaine in Two Different Doses for Postoperative Analgesia After Abdominal Hysterectomy: A Prospective, Randomized, Double-Blind Control Study.

MLA

Shah, Mahnaz S., et al. “Nalbuphine as an Intrathecal Adjuvant to 0.5% Hyperbaric Bupivacaine in Two Different Doses for Postoperative Analgesia After Abdominal Hysterectomy: A Prospective, Randomized, Double-Blind Control Study.” Cureus, vol. 14, no. 5, May 2022, p. e25044. EBSCOhost, https://doi.org/10.7759/cureus.25044.

APA

Shah, M. S., Masoodi, T., Hussain, S. Y., & Jain, D. (2022). Nalbuphine as an Intrathecal Adjuvant to 0.5% Hyperbaric Bupivacaine in Two Different Doses for Postoperative Analgesia After Abdominal Hysterectomy: A Prospective, Randomized, Double-Blind Control Study. Cureus, 14(5), e25044. https://doi.org/10.7759/cureus.25044

Chicago

Shah, Mahnaz S, Tahir Masoodi, Sana Y Hussain, and Dhruv Jain. 2022. “Nalbuphine as an Intrathecal Adjuvant to 0.5% Hyperbaric Bupivacaine in Two Different Doses for Postoperative Analgesia After Abdominal Hysterectomy: A Prospective, Randomized, Double-Blind Control Study.” Cureus 14 (5): e25044. doi:10.7759/cureus.25044.